Dr. André Veillette and his team have discovered why immunotherapy would work in some patients and not at all in others. This finding is published today in Nature.
The U.S. tech giant announces a new artificial-intelligence laboratory to boost its projects with the Montreal Institute for Learning Algorithms.
Letter to the Editor: Quantifying U.S. medical residency competitiveness in different fields
A joint research published today in Nature Communications has shown new molecular causes of brain cancer and leukemia.
Young children who watch too much television are at risk of victimization, social isolation and adopting violent and antisocial behaviour toward other students at age 13.
A study conducted by Dr. Francine Ducharme confirms that it’s not child’s age, but a respiratory viral detection that explains the high rate of hospitalization.
A new study published in the Journal of Clinical Investigation shows that when kidneys fail, urea that builds up in the blood can cause diabetes.
To mark World Hepatitis Day, Naglaa Shoukry discusses possible solutions to eliminate hepatitis C.
Valérie Marcil awarded a research grant by Institut de France-affiliated Foundation Yves Cotrel.
The results of a new study conducted by Dr. Anick Bérard demonstrate that the use of nicotine patches or the drug Zyban has positive effects has positive effects for the child and the mother.
This discovery made by researchers from CRCHUM has opened new treatment perspectives to perhaps, one day, cure people infected with the virus.
Dr. Liberman is leading a large international clinical to assess the effectiveness of a minimally invasive surgical approach for 150 patients with lung cancer.
The $ 15-million grant to the Centre for Commercialization of Cancer Immunotherapy (C3i) will go towards the development, application and commercialization of cancer immunotherapy.